Home Dalton Investment Named '2025 Outstanding Medical Device Investor' by National Innovation Center for High-Performance Medical Devices

Dalton Investment Named '2025 Outstanding Medical Device Investor' by National Innovation Center for High-Performance Medical Devices

Dec 18, 2025 18:37 CST Updated 18:37
MacroLux

Provider of Comprehensive Endoscopic Interventional Diagnosis and Treatment Solutions

Raytne

Ophthalmic New Drug and Therapeutic Device R&D Provider

Polaris Biology

Supplier of Single-Cell Precision Diagnosis Technology R&D and Clinical Applications

Image

Honor Express

Honor

DaoTong InvestmentRankedNational High-Performance Medical Device Innovation CenterTop Investment Institutions in the Medical Device Industry 2025". DaoTong Family EnterprisesMacroLux, Raytne, Polaris BiologyMultiple companies, including Polaris Biology, MacroLux, and Raytne, have been honored on the "2025 Top 100 Emerging Medical Device Companies" list.


To fully leverage the leading and radiating role of national-level innovation platforms, further activate industrial innovation momentum, effectively promote the high-quality development of the high-performance medical device industry, and accelerate the cultivation of new productive forces in China's medical equipment sector, the National Innovation Center for High-Performance Medical Devices has initiated and organized the "2025 Annual Medical Device Industry Innovation Ecosystem Insight Assessment."



DaoTong Investment

Top Investment Institutions in the Medical Device Industry 2025


Image



Daotong Family Enterprises

Polaris Biology,MacroLux, Raytne

Top 100 Emerging Companies in the Medical Device Industry 2025 Innovation Index


Image



DaoTong Family EnterpriseRaytne

2025 Medical Device Industry Ophthalmology Diagnosis and Treatment Field Innovation Index


Image


United in purpose, steady in action, and visionary in progress, Dao Tong has developed intoLeading in ChinaIndustrial investment institutions, with in-depth presence in the fields of medical devices, innovative technologies, and biomedicine.Systematic Layoutand investment, achieving excellent investment performance and many successful cases. As an early to mid-stage investment institution, we are pleased to see the value brought by perseverance. The results of several innovative technology investments from our earlier layout are now bearing fruit, with multiple projects achieving technological innovation outcomes.The First in China


In the future, Dao Tong Investment will continue to focus on its professional investment areas, persistently strive forward, support more outstanding companies in achieving leapfrog growth, and create value for the advancement and development of the medical industry.



END



图片

图片




图片

ID:daltonventure

Long press to follow


RECOMMEND

Recommended Reading

Dalton Honor

DaoTong Investment Honored as Top 10 Best Early-Stage Venture Capital Institutions and Best Medical Device Field Investment Institution in China by CVSource 2024.TOP20

DaoTong Investment Honored as One of the Top 100 Venture Capital Institutions in China and Top 30 Healthcare Investment Institutions in China by Zero2IPO in 2024

Sun Qi from Daotong Investment Honored as Top 20 Best Healthcare Industry Investors in China and Top 50 Best Early-Stage Investors in China by CVSource 2024

DaoTong Investment Honored as "2024 TOP 30 Early-Stage Investment Institutions Recognized by LPs" by LP Club

DaoTong Investment Honored as "Top 10 Best Early-Stage Investment Institutions in China for 2023" by CVSource

Sun Qi from Daotong Investment Selected as One of "Top 50 Best Early-stage Investors of the Year 2022-2023" by ChinaVenture

Daotong Investment Honored as CVCRI "Top 30 Best Healthcare Investment Institutions in China for 2023"

Daotong Investment Honored as One of the "Top 60 Best Venture Capital Institutions of 2022-2023" by Investor Network

Daotong Investment Honored as One of the "Top 50 Best Investment Institutions of the Year" by First Financial

Daotong Investment Wins the "Top 30 Best Investment Institutions in China's Healthcare Sector for 2022-2023" by Rongzhong List

DaoTong Investment Ranks on the "Top 20 Value Creation List of Investment Institutions' Soft Power" in the 2023 Fund Weekly.

DaoTong Investment Honored in CVSource’s 2022 “Top 100 Best Venture Capital Institutions in China”

DaoTong Investment Honored in CVSource's 2022 "Top 20 Best Investment Institutions in the Medical Device Field" List

Dao Tong Investment Honored with VBdata "Pengcheng Award - Top 20 Medical Device Investment Institutions of the Year"

Daotong Investment Honored as FOFWEEKLY "Top 20 Most LP-Attentive Investment Institutions in Healthcare Sector 2021"

Daotong Investment Selected as One of the "Top 100 Best Venture Capital Institutions in China" for Four Consecutive Years

Daotong Investment Honored as "Top 20 Best Investment Institutions in the Healthcare Field for 2021" by Investors

DaoTong Investment Honored as CVCRI "Top 30 Best Healthcare Investment Institutions in China for 2021"

Sun Qi of Daotong Investment Selected for "CVSource 2020 Top 50 Best Early-Stage Investors in China"

Daotong Investment Ranked Among "Top 40 Most LP-Favored Investment Institutions of 2020-2021"

DaoTong Investment Wins "Best Early-Stage Investment Institution in China's Healthcare Industry for 2020-2021"

DaoTong Investment Consecutively Selected for "Top 100 Best Venture Capital Institutions in China" for Three Years

Daotong Investment Honored with "Top 30 Best Investment Institutions in the Healthcare Sector for 2020" and Other Awards

Daotong Investment Honored as CVCRI "Top 30 Best Healthcare Investment Institutions in China 2020"